This trial is examining the effectiveness of Moses Pulse laser on patients with benign prostate hypertrophy (BPH). The main outcome will be the change in blood loss during and after surgery. This study is being conducted in Tennessee, US.
The details
BPH is a common disorder that affects older men. It consists of an increase in the size of the prostate which might cause symptoms such as urinary incontinence (leakage of urine), urinary retention, or difficulties urinating.
Prior studies showed that Holmium laser enucleation of the prostate (HoLEP) positively impacts patients with BPH. It uses a laser to remove the tissue that is blocking urine flow. However, newer methods such as Moses Pulse laser enucleation of the prostate (MOLEP) improve laser delivery which may improve blood loss and surgery time.
This trial is evaluating the safety and effectiveness of MOLEP in patients with BPH. The main outcomes evaluated are blood loss during surgery and the duration of the surgery.
Who are they looking for?
This trial will be recruiting 42 participants with BPH. These patients must be any man requiring surgery with a prostate greater than 80 grams.
Participants must not be taking blood thinner tablets before the surgery.
How will it work
There will be two groups in this trial. Participants will either receive HoLEP or MOLEP. The main outcome to be measure will be blood loss during surgery and the duration of the procedure.
